Schreiber S - Search Results

1

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

Schreiber S, Fedorak RN, Nielsen OH, Wild G, Williams CN, Nikolaus S, Jacyna M, Lashner BA, Gangl A, Rutgeerts P, Isaacs K, van Deventer SJ, Koningsberger JC, Cohard M, LeBeaut A, Hanauer SB. Schreiber S, et al. Gastroenterology. 2000 Dec;119(6):1461-72. doi: 10.1053/gast.2000.20196. Gastroenterology. 2000. PMID: 11113067 Clinical Trial.

2

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease.

Schreiber S, Heinig T, Thiele HG, Raedler A. Schreiber S, et al. Gastroenterology. 1995 May;108(5):1434-44. doi: 10.1016/0016-5085(95)90692-4. Gastroenterology. 1995. PMID: 7729636

3

Tumour necrosis factor inhibition by oxpentifylline and intestinal inflammation in Crohn's disease.

Bauditz J, Rückert Y, Raedler A, Nikolaus S, Lochs H, Schreiber S. Bauditz J, et al. Among authors: schreiber s. Lancet. 1995 Jun 3;345(8962):1445. doi: 10.1016/s0140-6736(95)92635-6. Lancet. 1995. PMID: 7760641 No abstract available.

4

Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.

Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Schreiber S, et al. Gastroenterology. 1995 Jan;108(1):21-33. doi: 10.1016/0016-5085(95)90004-7. Gastroenterology. 1995. PMID: 7806044

5

Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.

Schreiber S, Howaldt S, Schnoor M, Nikolaus S, Bauditz J, Gasché C, Lochs H, Raedler A. Schreiber S, et al. N Engl J Med. 1996 Mar 7;334(10):619-23. doi: 10.1056/NEJM199603073341002. N Engl J Med. 1996. PMID: 8592524 Free article. Clinical Trial.

6

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.

Bauditz J, Haemling J, Ortner M, Lochs H, Raedler A, Schreiber S. Bauditz J, et al. Among authors: schreiber s. Gut. 1997 Apr;40(4):470-4. doi: 10.1136/gut.40.4.470. Gut. 1997. PMID: 9176073 Free PMC article. Clinical Trial.

7

Photodynamic therapy of nonresectable cholangiocarcinoma.

Ortner MA, Liebetruth J, Schreiber S, Hanft M, Wruck U, Fusco V, Müller JM, Hörtnagl H, Lochs H. Ortner MA, et al. Among authors: schreiber s. Gastroenterology. 1998 Mar;114(3):536-42. doi: 10.1016/s0016-5085(98)70537-2. Gastroenterology. 1998. PMID: 9496944

8

Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation.

Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Nikolaus S, et al. Among authors: schreiber s. Gut. 1998 Apr;42(4):470-6. doi: 10.1136/gut.42.4.470. Gut. 1998. PMID: 9616306 Free PMC article.

9

Activation of nuclear factor kappa B inflammatory bowel disease.

Schreiber S, Nikolaus S, Hampe J. Schreiber S, et al. Gut. 1998 Apr;42(4):477-84. doi: 10.1136/gut.42.4.477. Gut. 1998. PMID: 9616307 Free PMC article.

10

Association between intraepithelial Escherichia coli and colorectal cancer.

Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, Lochs H. Swidsinski A, et al. Among authors: schreiber s. Gastroenterology. 1998 Aug;115(2):281-6. doi: 10.1016/s0016-5085(98)70194-5. Gastroenterology. 1998. PMID: 9679033

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,824 results

Search Page

Filters